The FDA have approved Novo Nordisk's weight loss drugs, Saxenda and Wegovy, for use in teenagers. But how effective are they, and what are the potential consequences of normalising the use of injectable drugs for weight loss in kids as young as 12? Join Louise as she takes us through the Novo Nordisk funded clinical trials. Are these drugs really the magic pill they're touted to be? Or are we taking unjustified risks in the name of fat eradication?
Hosted on Acast. See acast.com/privacy for more information.